Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integrated Biopharma Inc (OP:INBP)

0.3043 UNCHANGED
Streaming Delayed Price Updated: 3:34 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3043
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3043
Today's Range 0.3043 - 0.3043
52wk Range 0.2161 - 0.4200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
Via ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
Via ACCESS Newswire

Performance

YTD
-4.9%
-4.9%
1 Month
+5.1%
+5.1%
3 Month
+7.5%
+7.5%
6 Month
+4.9%
+4.9%
1 Year
-4.9%
-4.9%

More News

Read More
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024
Via ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
Via ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023
Via ACCESSWIRE
Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022
Via ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022
Via ACCESSWIRE
Integrated BioPharma Announces Change in Directors
From Integrated BioPharma, Inc.
Via AccessWire
Topics Cannabis
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Multiple Miners Make Their Way In for Q1 OTC Market Index Rebalancing
Via Benzinga
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Announces Launch of Investors Website
From Integrated BioPharma, Inc.
Via AccessWire

Frequently Asked Questions

Is Integrated Biopharma Inc publicly traded?
Yes, Integrated Biopharma Inc is publicly traded.
What exchange does Integrated Biopharma Inc trade on?
Integrated Biopharma Inc trades on the OTC Traded
What is the ticker symbol for Integrated Biopharma Inc?
The ticker symbol for Integrated Biopharma Inc is INBP on the OTC Traded
What is the current price of Integrated Biopharma Inc?
The current price of Integrated Biopharma Inc is 0.3043
When was Integrated Biopharma Inc last traded?
The last trade of Integrated Biopharma Inc was at 11/03/25 03:34 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.